This observational study will describe the long term safety adn clinical outcomes of ZALTRAP in combination with FOLFORI in patients treated in daily practice for metastatic colorectal cancer after failure of oxaliplatin-based regimen.
Each patient will receive their treatment with ZALTRAP and FOLFORI as their physician prescribes but data will be collected from the first dose or until death. No pre-defined visit schedule is planned and visits will take place at routine clinical practice. Treatment related decisons will be made solely by the treating physician.
